• About Us
  • Services
  • Process
  • News
  • Contact
BioPortUSA
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Commercialization
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Commercialization
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
22 Oct

Myth vs Reality for Life Sciences Companies Entering the US Market

Over the years, it has come to my attention that many international life science companies think that doing business in the U.S. Healthcare Market can't be that hard. After all, they speak English, they have traveled to Disney World, and have attended conferences in the United States. All they need to do is participate at an industry trade show, sign up a distributor, and watch the money roll in.  If it were only that easy. Unfortunately, the reality of U.S. market entry is a much more challenging proposition. There are are cultural nuances in how business is done and decisions are made that differ from the process in foreigners home country.  The interview with Bill Kenney from MEET touches on some of the misconceptions that exist, and separates Myth from Reality.

Learn more about MEET

  • Facebook
  • Twitter
  • LinkedIn
  • Print
  • Email
Latest Articles
#
Navigating Health Tech Across Boarders
Apr 29, 2025, 10:33 AM
Navigating the Evolving Regulatory Landscape
Apr 22, 2025, 12:21 PM
Unlocking Success in MedTech: A Powerful Partnership for Growth
Jan 9, 2025, 2:39 PM

About BioPortUSA   

BioPort USA

The Gateway For Life Sciences Into The United States

Contact

United States

Mark Lesselroth, CEO

mark(at)bioportusa.com

+1 315 569 0642

©2017—2025 BioPortUSA All rights reserved.

About Us   Services    Process    Contact    Privacy